These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. I Li S; Guo JH; Lu J; Wang C; Wu H; Wang H; Zha J; Fan R Cancer Radiother; 2021 Jun; 25(4):340-349. PubMed ID: 33455874 [TBL] [Abstract][Full Text] [Related]
3. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis]. Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343 [No Abstract] [Full Text] [Related]
4. Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis. Li S; Li L; Li B; Wang W Br J Radiol; 2020 Aug; 93(1112):20190279. PubMed ID: 32464068 [TBL] [Abstract][Full Text] [Related]
5. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis. Zhang XP; Wang K; Li N; Zhong CQ; Wei XB; Cheng YQ; Gao YZ; Wang H; Cheng SQ BMC Cancer; 2017 Dec; 17(1):902. PubMed ID: 29282010 [TBL] [Abstract][Full Text] [Related]
6. Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma. Hong D; Zhou Y; Wan X; Su H; Shao H BMC Cancer; 2021 Sep; 21(1):1020. PubMed ID: 34521375 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis. Lin LW; Yan LY; Ke K; Yang WZ; Lin JQ; Huang N Brachytherapy; 2023; 22(6):858-871. PubMed ID: 37574351 [TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of CT-Guided Iodine-125 Brachytherapy for Portal Vein Tumor Thrombus in Hepatocellular Carcinoma. Qiu Z; Yu C; Qiu X; Li Q; Li J; Chen Z; Chang S; Zhang S; Fan G; Wang S Acad Radiol; 2023 Sep; 30 Suppl 1():S53-S60. PubMed ID: 36882354 [TBL] [Abstract][Full Text] [Related]
10. Endovascular implantation of Sun H; Zhang M; Liu R; Liu Y; Hou Y; Wu C Future Oncol; 2018 May; 14(12):1165-1176. PubMed ID: 29334777 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus: chemoembolization and stent combined with iodine-125 seed. Chuan-Xing L; Xu H; Bao-Shan H; Yong L; Pei-Jian S; Xian-Yi Y; Xiao-Ning L; Li-Gong L Cancer Biol Ther; 2011 Nov; 12(10):865-71. PubMed ID: 22037354 [TBL] [Abstract][Full Text] [Related]
12. Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study. Huang M; Lin Q; Wang H; Chen J; Bai M; Wang L; Zhu K; Jiang Z; Guan S; Li Z; Qian J; Li M; Pang P; Shan H Eur Radiol; 2016 Oct; 26(10):3428-36. PubMed ID: 26792430 [TBL] [Abstract][Full Text] [Related]
13. Integrated I-125 Seed Implantation Combined with Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombus. Wang W; Wang C; Shen J; Ren B; Yin Y; Yang J; Tang H; Zhu X; Ni C Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1570-1578. PubMed ID: 34117503 [TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial. Yang M; Fang Z; Yan Z; Luo J; Liu L; Zhang W; Wu L; Ma J; Yang Q; Liu Q J Cancer Res Clin Oncol; 2014 Feb; 140(2):211-9. PubMed ID: 24374800 [TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis. Zhang X; Wang K; Wang M; Yang G; Ye X; Wu M; Cheng S Oncotarget; 2017 Apr; 8(17):29416-29427. PubMed ID: 28177886 [TBL] [Abstract][Full Text] [Related]
16. Portal Vein Stenting Combined with Iodine-125 Seeds Endovascular Implantation Followed by Transcatheter Arterial Chemoembolization for Treatment of Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus. Sun JH; Zhou T; Zhu T; Zhang Y; Nie C; Ai J; Zhou G; Zhang A; Dong MJ; Wang WL; Zheng SS Biomed Res Int; 2016; 2016():3048261. PubMed ID: 27999793 [TBL] [Abstract][Full Text] [Related]
17. Predictive factors of benefit from iodine-125 brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis. Lin J; Jiang H; Yang W; Jiang N; Zheng Q; Huang N; Wang X; Li A; Huang J Brachytherapy; 2019; 18(2):233-239. PubMed ID: 30467014 [TBL] [Abstract][Full Text] [Related]
18. TACE with portal vein radioactive seeds for HCC with portal vein tumor thrombus: a meta-analysis. Yang SB; Zhang JH; Fu YF; Wang R Minim Invasive Ther Allied Technol; 2022 Aug; 31(6):856-864. PubMed ID: 35238280 [TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization combined with computed tomography-guided 125iodine implantation enhances survival in hepatocellular carcinoma patients with portal vein tumor thrombus. Hu HT; Luo JP; Li HL; Guo CY; Yao QJ; Geng X; Jiang L Oncotarget; 2017 Apr; 8(17):29258-29268. PubMed ID: 28418927 [TBL] [Abstract][Full Text] [Related]
20. Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Huo YR; Eslick GD JAMA Oncol; 2015 Sep; 1(6):756-65. PubMed ID: 26182200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]